1 April 1999 in International Immunology
Although T cell clone monospecificity is ensured by several allelic exclusion processes operating at either the genotypic or phenotypic levels, clones expressing two distinct αβ or γδ TCR have been described in several instances. Thus far, the origin of dual TCR-expressing cells and the homeostatic mechanisms controlling the size of this subset in the periphery remain poorly understood. In the course of a phenotypic analysis of γδ T cells in HIV-infected patients, we detected the presence of a T cell subset stained by both Vδ2- and Vδ3-specific mAb, which represented a large fraction (up to 16.5%) of γδ peripheral blood lymphocytes (PBL) in one HIV patient. The presence of two distinct functional δ chains on these cells was confirmed by phenotypic and molecular analysis of TCR transcripts expressed by Vδ2+Vδ3+ T cell clones derived from this patient. For 18 months, the absolute number of these cells varied similarly to the other PBL subsets, before becoming undetectable in blood samples. Moreover, most of these cells expressed CD8 receptors, which are classically found on activated, but not resting, γδ T cells. Taken together, these data suggest that dual TCR-expressing T cells are subjected to peripheral expansions and contractions presumably following antigen recognition, which would argue against a systematic counter-selection of these cells during peripheral antigen-driven responses.
1 December 1992 in Proceedings of the National Academy of Sciences
We have constructed a hybrid cDNA coding for a fusion protein between human interleukin 2 and a truncated heavy chain from human immunoglobulin M. The protein encoded by this cDNA contains the entire interleukin 2 sequence including its signal peptide, fused at its C terminus to domains 2 to 4 of the immunoglobulin heavy-chain constant region. Cells transfected with the hybrid cDNA secrete multimeric forms of the fusion protein, which bind specifically to cells bearing high-affinity interleukin 2 receptors. This binding leads either to T-cell proliferation or, if complement is added, to T-cell death. Multimeric forms of the fusion protein with a molecular mass above 500 kDa mediate complement-dependent lysis but trigger proliferation inefficiently when compared with forms with a low molecular mass (< 500 kDa). In contrast, the latter efficiently mediate T-cell proliferation without inducing complement-dependent lysis. The high molecular mass fusion proteins could thus constitute valuable tools for specific immunosuppression in humans.
1 January 1996 in Journal of Immunological Methods
1 July 1995 in Annals of the New York Academy of Sciences
1 November 1998 in Research in Immunology
4 January 2025 in Open Access Government
Microbiomes should be incorporated into The One Health Joint Plan of Action: The One Health Joint Plan of Action was created by major international organizations to tackle global health issues related to human, animal, plant, and environmental health. This article emphasizes the importance of integrating microbiomes into this framework to enhance health systems and prevention strategies. In 2022, four major international organizations—the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH)—introduced the One Health Joint Plan of Action (2022-2026). This initiative outlines an ambitious framework to address global health challenges at the intersection of human, animal, plant, and environmental health. In particular, the document recognizes that individual disease-causing microorganisms and those that carry antimicrobial resistance (AMR) interact at this intersection. Yet despite its comprehensive scope, the plan omits explicit mention of microbiomes. This omission undervalues the potential for microbiome-based solutions to address global health challenges and misses an opportunity to move towards more proactive prevention through microbiome-based approaches.